BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16719832)

  • 1. Pharmacological and clinical studies on purine nucleoside analogs--new anticancer agents.
    Lech-Maranda E; Korycka A; Robak T
    Mini Rev Med Chem; 2006 May; 6(5):575-81. PubMed ID: 16719832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel purine nucleoside analogues for hematological malignancies.
    Korycka A; Lech-Marańda E; Robak T
    Recent Pat Anticancer Drug Discov; 2008 Jun; 3(2):123-36. PubMed ID: 18537755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity.
    Robak T; Lech-Maranda E; Korycka A; Robak E
    Curr Med Chem; 2006; 13(26):3165-89. PubMed ID: 17168705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias.
    Robak T; Robak P
    Curr Pharm Des; 2012; 18(23):3373-88. PubMed ID: 22591387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Older and new purine nucleoside analogs for patients with acute leukemias.
    Robak P; Robak T
    Cancer Treat Rev; 2013 Dec; 39(8):851-61. PubMed ID: 23566572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purine nucleoside analogues for the treatment of hematological malignancies: pharmacology and clinical applications.
    Robak T; Korycka A; Kasznicki M; Wrzesien-Kus A; Smolewski P
    Curr Cancer Drug Targets; 2005 Sep; 5(6):421-44. PubMed ID: 16178817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three new drugs for acute lymphoblastic leukemia: nelarabine, clofarabine, and forodesine.
    Larson RA
    Semin Oncol; 2007 Dec; 34(6 Suppl 5):S13-20. PubMed ID: 18086342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.
    Robak T; Korycka A; Lech-Maranda E; Robak P
    Molecules; 2009 Mar; 14(3):1183-226. PubMed ID: 19325518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New nucleoside analogs in the treatment of hematological disorders.
    Szafraniec SI; Stachnik KJ; Skierski JS
    Acta Pol Pharm; 2004; 61(3):223-32. PubMed ID: 15481249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purine nucleoside antimetabolites in development for the treatment of cancer.
    Parker WB; Secrist JA; Waud WR
    Curr Opin Investig Drugs; 2004 Jun; 5(6):592-6. PubMed ID: 15242246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forodesine (BCX-1777, Immucillin H)--a new purine nucleoside analogue: mechanism of action and potential clinical application.
    Korycka A; Błoński JZ; Robak T
    Mini Rev Med Chem; 2007 Sep; 7(9):976-83. PubMed ID: 17897085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity.
    Lech-Maranda E; Korycka A; Robak T
    Mini Rev Med Chem; 2009 Jun; 9(7):805-12. PubMed ID: 19519505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nelarabine: a novel purine antimetabolite antineoplastic agent.
    Buie LW; Epstein SS; Lindley CM
    Clin Ther; 2007 Sep; 29(9):1887-99. PubMed ID: 18035189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purine and pyrimidine nucleoside analogs.
    Plunkett W; Gandhi V
    Cancer Chemother Biol Response Modif; 2001; 19():21-45. PubMed ID: 11686015
    [No Abstract]   [Full Text] [Related]  

  • 15. Clofarabine and nelarabine: two new purine nucleoside analogs.
    Gandhi V; Plunkett W
    Curr Opin Oncol; 2006 Nov; 18(6):584-90. PubMed ID: 16988579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders.
    Tallman MS; Hakimian D
    Blood; 1995 Oct; 86(7):2463-74. PubMed ID: 7670093
    [No Abstract]   [Full Text] [Related]  

  • 17. Nucleoside analogues and nucleobases in cancer treatment.
    Galmarini CM; Mackey JR; Dumontet C
    Lancet Oncol; 2002 Jul; 3(7):415-24. PubMed ID: 12142171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel 6-substituted amino-9-(β-d-ribofuranosyl)purine analogs and their bioactivities on human epithelial cancer cells.
    Tuncbilek M; Kucukdumlu A; Guven EB; Altiparmak D; Cetin-Atalay R
    Bioorg Med Chem Lett; 2018 Feb; 28(3):235-239. PubMed ID: 29326016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purine nucleoside therapy of low-grade follicular lymphoma.
    Piro LD
    Ann Oncol; 1996; 7 Suppl 6():S41-7. PubMed ID: 9010578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies.
    Robak T
    Drugs Aging; 2005; 22(12):983-1012. PubMed ID: 16363884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.